Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses.

Ryz NR, Patterson SJ, Zhang Y, Ma C, Huang T, Bhinder G, Wu X, Chan J, Glesby A, Sham HP, Dutz JP, Levings MK, Jacobson K, Vallance BA.

Am J Physiol Gastrointest Liver Physiol. 2012 Dec 15;303(12):G1299-311. doi: 10.1152/ajpgi.00320.2012. Epub 2012 Sep 27.

2.

Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis.

Ryz NR, Lochner A, Bhullar K, Ma C, Huang T, Bhinder G, Bosman E, Wu X, Innis SM, Jacobson K, Vallance BA.

Am J Physiol Gastrointest Liver Physiol. 2015 Nov 1;309(9):G730-42. doi: 10.1152/ajpgi.00006.2015. Epub 2015 Sep 3.

3.

Vitamin D deficiency: protective against enteric infection?

Christakos S.

Am J Physiol Gastrointest Liver Physiol. 2012 Dec 15;303(12):G1297-8. doi: 10.1152/ajpgi.00405.2012. Epub 2012 Nov 1. No abstract available.

4.

Citrobacter rodentium-induced colitis: A robust model to study mucosal immune responses in the gut.

Koroleva EP, Halperin S, Gubernatorova EO, Macho-Fernandez E, Spencer CM, Tumanov AV.

J Immunol Methods. 2015 Jun;421:61-72. doi: 10.1016/j.jim.2015.02.003. Epub 2015 Feb 19.

PMID:
25702536
5.

Regulatory T cells promote a protective Th17-associated immune response to intestinal bacterial infection with C. rodentium.

Wang Z, Friedrich C, Hagemann SC, Korte WH, Goharani N, Cording S, Eberl G, Sparwasser T, Lochner M.

Mucosal Immunol. 2014 Nov;7(6):1290-301. doi: 10.1038/mi.2014.17. Epub 2014 Mar 19.

PMID:
24646939
6.

STAT3 activation in Th17 and Th22 cells controls IL-22-mediated epithelial host defense during infectious colitis.

Backert I, Koralov SB, Wirtz S, Kitowski V, Billmeier U, Martini E, Hofmann K, Hildner K, Wittkopf N, Brecht K, Waldner M, Rajewsky K, Neurath MF, Becker C, Neufert C.

J Immunol. 2014 Oct 1;193(7):3779-91. doi: 10.4049/jimmunol.1303076. Epub 2014 Sep 3.

7.

The cell surface receptor Slamf6 modulates innate immune responses during Citrobacter rodentium-induced colitis.

van Driel B, Wang G, Liao G, Halibozek PJ, Keszei M, O'Keeffe MS, Bhan AK, Wang N, Terhorst C.

Int Immunol. 2015 Sep;27(9):447-57. doi: 10.1093/intimm/dxv029. Epub 2015 May 8.

8.

Intestinal epithelium-specific MyD88 signaling impacts host susceptibility to infectious colitis by promoting protective goblet cell and antimicrobial responses.

Bhinder G, Stahl M, Sham HP, Crowley SM, Morampudi V, Dalwadi U, Ma C, Jacobson K, Vallance BA.

Infect Immun. 2014 Sep;82(9):3753-63. doi: 10.1128/IAI.02045-14. Epub 2014 Jun 23.

11.

Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection.

Shiomi H, Masuda A, Nishiumi S, Nishida M, Takagawa T, Shiomi Y, Kutsumi H, Blumberg RS, Azuma T, Yoshida M.

Infect Immun. 2010 Jun;78(6):2653-66. doi: 10.1128/IAI.01343-09. Epub 2010 Mar 29.

12.

Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice.

Sokol H, Conway KL, Zhang M, Choi M, Morin B, Cao Z, Villablanca EJ, Li C, Wijmenga C, Yun SH, Shi HN, Xavier RJ.

Gastroenterology. 2013 Sep;145(3):591-601.e3. doi: 10.1053/j.gastro.2013.05.047. Epub 2013 May 31.

13.

Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma.

Simmons CP, Goncalves NS, Ghaem-Maghami M, Bajaj-Elliott M, Clare S, Neves B, Frankel G, Dougan G, MacDonald TT.

J Immunol. 2002 Feb 15;168(4):1804-12.

14.

The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium.

Murphy CT, Hall LJ, Hurley G, Quinlan A, MacSharry J, Shanahan F, Nally K, Melgar S.

Infect Immun. 2012 Aug;80(8):2712-23. doi: 10.1128/IAI.06319-11. Epub 2012 May 21.

15.

Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis.

Wlodarska M, Willing B, Keeney KM, Menendez A, Bergstrom KS, Gill N, Russell SL, Vallance BA, Finlay BB.

Infect Immun. 2011 Apr;79(4):1536-45. doi: 10.1128/IAI.01104-10. Epub 2011 Feb 14.

16.

Cytokine IL-6 is required in Citrobacter rodentium infection-induced intestinal Th17 responses and promotes IL-22 expression in inflammatory bowel disease.

Li L, Shi QG, Lin F, Liang YG, Sun LJ, Mu JS, Wang YG, Su HB, Xu B, Ji CC, Huang HH, Li K, Wang HF.

Mol Med Rep. 2014 Mar;9(3):831-6. doi: 10.3892/mmr.2014.1898. Epub 2014 Jan 14.

PMID:
24430732
17.

Polarizing the T helper 17 response in Citrobacter rodentium infection via expression of resistin-like molecule α.

Chen G, Chan AJ, Chung JI, Jang JC, Osborne LC, Nair MG.

Gut Microbes. 2014 May-Jun;5(3):363-8. doi: 10.4161/gmic.29100. Epub 2014 May 15.

18.

Resistin-like molecule α promotes pathogenic Th17 cell responses and bacterial-induced intestinal inflammation.

Osborne LC, Joyce KL, Alenghat T, Sonnenberg GF, Giacomin PR, Du Y, Bergstrom KS, Vallance BA, Nair MG.

J Immunol. 2013 Mar 1;190(5):2292-300. doi: 10.4049/jimmunol.1200706. Epub 2013 Jan 25.

20.

Identification of an innate T helper type 17 response to intestinal bacterial pathogens.

Geddes K, Rubino SJ, Magalhaes JG, Streutker C, Le Bourhis L, Cho JH, Robertson SJ, Kim CJ, Kaul R, Philpott DJ, Girardin SE.

Nat Med. 2011 Jun 12;17(7):837-44. doi: 10.1038/nm.2391.

PMID:
21666695

Supplemental Content

Support Center